Asthma Management System in Primary Care Based on Global Initiative for Asthma and Snell's Drug Interaction: Accuracy and Usability.
Accuracy
Asthma management system
Drug interaction
Global Initiative for Asthma
Primary care
Usability
Journal
Tanaffos
ISSN: 1735-0344
Titre abrégé: Tanaffos
Pays: Iran
ID NLM: 101308232
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
29
04
2021
accepted:
07
10
2021
entrez:
7
3
2023
pubmed:
8
3
2023
medline:
8
3
2023
Statut:
ppublish
Résumé
The two main pillars of asthma management include regular follow-up and using guidelines in the treatment process. Patient portals enable regular follow-up of disease, and guideline-based decision-support-systems can improve the use of guidelines in the treatment process. Based on the Global Initiative for Asthma (GINA) and Snell's drug interaction, asthma management system in primary care (AMSPC) includes the capabilities of both mentioned systems. This system was developed to improve regular follow-up and use GINA in the asthma management process. This study aimed to assess the accuracy and usability of the AMSPC based on the GINA and Snell's drug interaction. To assess the accuracy of the system, kappa test was used to calculate the degree of agreement between the suggestions made by the system and the physician's decision for a total of 64 patients selected through convenience sampling method. To assess usability, the Questionnaire for User Interface Satisfaction (QUIS) was used. The scores of the Kappa for the agreements between the system and the physician in determining "drug type and dosage", "follow-up time", and "drug interactions" were 0.90, 0.94, and 0.94, respectively. The average score of the QUIS was 8.6 out of 9. Due to the high accuracy of the system in computerizing the GINA and Snell's drug interaction, as well as its proper usability, it is expected that the system be widely used to improve asthma management and reduce drug interactions.
Sections du résumé
Background
UNASSIGNED
The two main pillars of asthma management include regular follow-up and using guidelines in the treatment process. Patient portals enable regular follow-up of disease, and guideline-based decision-support-systems can improve the use of guidelines in the treatment process. Based on the Global Initiative for Asthma (GINA) and Snell's drug interaction, asthma management system in primary care (AMSPC) includes the capabilities of both mentioned systems. This system was developed to improve regular follow-up and use GINA in the asthma management process. This study aimed to assess the accuracy and usability of the AMSPC based on the GINA and Snell's drug interaction.
Materials and Methods
UNASSIGNED
To assess the accuracy of the system, kappa test was used to calculate the degree of agreement between the suggestions made by the system and the physician's decision for a total of 64 patients selected through convenience sampling method. To assess usability, the Questionnaire for User Interface Satisfaction (QUIS) was used.
Results
UNASSIGNED
The scores of the Kappa for the agreements between the system and the physician in determining "drug type and dosage", "follow-up time", and "drug interactions" were 0.90, 0.94, and 0.94, respectively. The average score of the QUIS was 8.6 out of 9.
Conclusion
UNASSIGNED
Due to the high accuracy of the system in computerizing the GINA and Snell's drug interaction, as well as its proper usability, it is expected that the system be widely used to improve asthma management and reduce drug interactions.
Types de publication
Journal Article
Langues
eng
Pagination
193-200Informations de copyright
Copyright© 2022 National Research Institute of Tuberculosis and Lung Disease.
Références
Respir Med. 1994 Feb;88(2):83-8
pubmed: 8146419
Curr Opin Allergy Clin Immunol. 2017 Apr;17(2):99-103
pubmed: 28118238
Curr Opin Allergy Clin Immunol. 2015 Oct;15(5):397-401
pubmed: 26226354
Chest. 2013 Feb 1;143(2):511-523
pubmed: 23381316
Asthma Res Pract. 2017 Jan 6;3:1
pubmed: 28078100
Telemed J E Health. 2003 Summer;9(2):129-40
pubmed: 12855036
BMJ Open. 2014 Mar 04;4(3):e003759
pubmed: 24595132
Implement Sci. 2018 May 29;13(1):72
pubmed: 29843737
Stud Health Technol Inform. 2004;107(Pt 1):673-7
pubmed: 15360898
Expert Rev Respir Med. 2016;10(1):39-51
pubmed: 26610152
J Allergy Clin Immunol Pract. 2020 Mar;8(3):965-970.e4
pubmed: 31622684